Akamis Bio

Akamis Bio is a clinical-stage oncology company that develops Tumor-Specific Immuno-Gene (T-SIGn®) therapeutics aimed at enabling the immune system to target and eliminate solid tumors.
  • Clinical trials for cancer treatment
  • Immuno-stimulatory tumor gene therapy
  • Tumor-Specific Immuno-Gene (T-SIGn®) therapeutics
Size
Small
Phone
N/A
Website
psioxus.com
Email
N/A
Locations
4-10 The Quadrant, OX14 3YS
01235835328
9:00 - 17:00
Digital Popularity
Popularity over time
Social Media
Company Details
Akamis Bio is operated by Akamis Bio Limited and is a Active company incorporated on 17 November 2006 with the registered office located in Sandwich, Kent. Akamis Bio Limited was registered 19 years ago.
Status
Active
Size
Small
Directors
11
Age
19 years old
Employees
30
Turnover
£13.31M
Total Assets
£28.84M
Cash in Bank
£13.38M
Total Liabilities
-£18.17M
J. Duncan Higgons
Director • Non Executive Director • American • Lives in United States • Born in Feb 1955
Howard E Davis JR
Director • American • Lives in United States • Born in May 1973
Lars Gredsted
Director • Senior Principal Lundbeckfonden Biocapit • Danish • Lives in Denmark • Born in Feb 1974
Dr Christopher Bowden
Director • Director • American • Lives in United States • Born in Mar 1961 • Chief Medical Officer
Matthew Foy
Director • Venture Capitalist • British • Lives in UK • Born in Apr 1980
Robin Lewis Lincoln
Director • Portfolio Operating Partner • British • Lives in UK • Born in Mar 1971
More information on Akamis Bio Limited